Unlocking NuriPep 1653 From Common Pea Protein: A Potent Antimicrobial Peptide to Tackle a Pan-Drug Resistant Acinetobacter baumannii
While the antibiotic era has come and gone, antimicrobial peptides (AMPs) hold promise as novel therapies to treat multidrug resistant (MDR) pathogens in an age where the threat of multidrug resistance escalates worldwide. Here, we report the bactericidal properties of NuriPep 1653, a novel 22 mer a...
Main Authors: | Niamh Maire Mohan, Amine Zorgani, Gael Jalowicki, Alish Kerr, Nora Khaldi, Marta Martins |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.02086/full |
Similar Items
-
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
by: Pedro V. Baptista, et al.
Published: (2018-07-01) -
Mapping Global Prevalence of <i>Acinetobacter baumannii</i> and Recent Vaccine Development to Tackle It
by: Chaoying Ma, et al.
Published: (2021-06-01) -
The values and principles underpinning community engagement approaches to tackling antimicrobial resistance (AMR)
by: Jessica Mitchell, et al.
Published: (2019-12-01) -
A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii
by: Sung-Pang Chen, et al.
Published: (2021-06-01) -
Multidrug-Resistant Acinetobacter baumannii in Veterinary Clinics, Germany
by: Sabrina Zordan, et al.
Published: (2011-09-01)